Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
NTLA
ACCE ResearchedIntellia Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$13.26
-1.63%today
MKT CAP
$1.6B
NEXT EARNINGS
Feb 26
Analysis in progress.
+57.1% · 1Y
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.